Production (Stage)
CorMedix Inc.
CRMD
$12.36
$0.100.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 53.32% | 584.89% | 80.38% | 2.17% | 1.95% |
| Total Depreciation and Amortization | 21.09% | 72.74% | 0.65% | 252.75% | 16.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.03% | 8.25% | -2.73% | -47.56% | 98.05% |
| Change in Net Operating Assets | 77.57% | -68.49% | -865.18% | 76.33% | -295.27% |
| Cash from Operations | 451.53% | 58.87% | 2.78% | 18.89% | -61.09% |
| Capital Expenditure | -3.03% | -1.02% | 71.84% | 43.23% | 79.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.27% | -104.65% | 0.44% | -30.01% | 907.74% |
| Cash from Investing | 35.96% | -104.81% | 0.84% | -29.92% | 1,396.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -37.27% | -19.44% | 1,076.68% | -- | -- |
| Repurchase of Common Stock | -1,822.64% | -- | 100.00% | -43.67% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -46.01% | -19.82% | 1,232.04% | 1,188.16% | -120.76% |
| Foreign Exchange rate Adjustments | 116.67% | -400.00% | 500.00% | 87.50% | -133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 377.82% | -20.48% | 200.47% | 20.66% | 12.55% |